Literature DB >> 19838821

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

Jorge J Palop1, Lennart Mucke.   

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD), target specific and functionally connected neuronal networks, raising the possibility that neurodegeneration may spread through abnormal patterns of neural network activity. AD is associated with high levels of amyloid-beta (A beta) peptides in the brain, synaptic depression, aberrant excitatory neuronal activity, and cognitive decline. However, the relationships among these alterations and their underlying mechanisms are poorly understood. In experimental models of AD, high concentrations of pathogenic A beta assemblies reduce glutamatergic transmission and enhance long-term depression at the synaptic level. At the network level, they cause dysrhythmias, including neuronal synchronization, epileptiform activity, seizures, and postictal suppression. Both synaptic depression and aberrant network synchronization likely interfere with activity-dependent synaptic regulation, which is critical for learning and memory. Abnormal patterns of neuronal activity across functionally connected brain regions may also trigger and perpetuate trans-synaptic mechanisms of neurodegeneration. It remains to be determined if synaptic depression and network dysrhythmias are mechanistically related, which of them is primary or secondary, and whether normalization of one will prevent the other as well as cognitive dysfunction in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838821      PMCID: PMC3319077          DOI: 10.1007/s12017-009-8097-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  58 in total

1.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 2.  Role of neurotrophins in central synapse formation and stabilization.

Authors:  Carlos Vicario-Abejón; David Owens; Ronald McKay; Menahem Segal
Journal:  Nat Rev Neurosci       Date:  2002-12       Impact factor: 34.870

3.  Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice.

Authors:  E Masliah; M Alford; M Mallory; E Rockenstein; D Moechars; F Van Leuven
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

Review 4.  Homeostatic plasticity in the developing nervous system.

Authors:  Gina G Turrigiano; Sacha B Nelson
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

5.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

6.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

7.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits.

Authors:  Jorge J Palop; Brian Jones; Lisa Kekonius; Jeannie Chin; Gui-Qiu Yu; Jacob Raber; Eliezer Masliah; Lennart Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

10.  Functional deactivations: change with age and dementia of the Alzheimer type.

Authors:  Cindy Lustig; Abraham Z Snyder; Mehul Bhakta; Katherine C O'Brien; Mark McAvoy; Marcus E Raichle; John C Morris; Randy L Buckner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-07       Impact factor: 11.205

View more
  72 in total

Review 1.  Episodic memory on the path to Alzheimer's disease.

Authors:  Michela Gallagher; Ming Teng Koh
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

2.  Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Authors:  Deepti Putcha; Michael Brickhouse; Kelly O'Keefe; Caroline Sullivan; Dorene Rentz; Gad Marshall; Brad Dickerson; Reisa Sperling
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

Review 3.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

Review 4.  The rationale for deep brain stimulation in Alzheimer's disease.

Authors:  Zaman Mirzadeh; Ausaf Bari; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2015-10-06       Impact factor: 3.575

Review 5.  Homeostatic disinhibition in the aging brain and Alzheimer's disease.

Authors:  Marc Gleichmann; Vivian W Chow; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

7.  Rescue of homeostatic regulation of striatal excitability and locomotor activity in a mouse model of Huntington's disease.

Authors:  Yumei Cao; David Bartolomé-Martín; Naama Rotem; Carlos Rozas; Shlomo S Dellal; Marcelo A Chacon; Bashkim Kadriu; Maria Gulinello; Kamran Khodakhah; Donald S Faber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

8.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

9.  Atrophy and lower regional perfusion of temporo-parietal brain areas are correlated with impairment in memory performances and increase of EEG upper alpha power in prodromal Alzheimer's disease.

Authors:  Vito Davide Moretti
Journal:  Am J Neurodegener Dis       Date:  2015-09-10

10.  A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.

Authors:  Qiang Liu; Xitao Xie; Ronald J Lukas; Paul A St John; Jie Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.